Dr. Robert Jeron Strickmeyer, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7388 Turfway Rd, Florence, KY 41042 Phone: 859-525-0005 Fax: 859-525-8806 |
Dr. Jeffrey Dawson Reichard, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7388 Turfway Rd, Florence, KY 41042 Phone: 859-525-0005 Fax: 859-585-8806 |
Arvin Asim Demetria Ejaz, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7388 Turfway Rd, Florence, KY 41042 Phone: 859-525-0005 Fax: 859-525-8806 |
Kevin Patrick Fitzgerald, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7388 Turfway Rd, Florence, KY 41042 Phone: 859-525-0005 Fax: 859-525-8806 |
News Archive
This week, the National Advisory Committee on Immunization updated and strengthened its statement related to the use of rotavirus vaccines in Canada. Rotavirus infection is the most common cause of severe gastroenteritis in children under the age of three. The NACI statement now includes Grade A recommendations (good evidence to recommend immunization) for healthy and preterm infants.
Parents may be surprised, even disappointed, to find out they don't influence whether their teen tries alcohol. But now for some good news: Parenting style strongly and directly affects teens when it comes to heavy drinking - defined as having five or more drinks in a row - according to a new Brigham Young University study.
A new grant to the Indiana University Center for Aging Research from the National Institute on Aging funds the first study to assess the potential benefits and harms to family members of early dementia screening of older adults.
The number and intensity of storms and other extreme weather events are on the increase all over the world. The latest study by the Medical University of Vienna in cooperation with the US Centers for Disease Control and Prevention uses the example of one of the largest American series of tornados of all times to show that the risk of injury can be reduced significantly with the use of certain media.
Oncolytics Biotech Inc. today announced that it has received approval from the Belgian Federal Agency for Medicines and Health Products (FAMHP) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that was agreed to by U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA).
› Verified 2 days ago